Skip to main content

Table 1 Background of subjects

From: Evaluation of the efficacy of drug treatment based on measurement of the oxidative stress, using reactive oxygen metabolites and biological antioxidant potential, in children with autism spectrum disorder and attention deficit hyperactivity disorder

Age(y)
 Means ± SD8.62 ± 2.46
 Median8
 Maximum14
 Minimum4
Sex
 Male38 (76.0%)
 Female12 (24.0%)
Gender comparison by age group
 4–6 y (n = 9)
  Male6 (66.7%)
  Female3 (33.3%)
 7–14 y (n = 41)
  Male32 (78.0%)
  Female9 (22.0%)
Druga
 Guanfacine Hydrochloride25 (50.0%)
 Methylphenidate Hydrochloride18 (36.0%)
 Risperidone12 (24.0%)
 Aripiprazole11 (22.0%)
 Atomoxetine Hydrochloride9 (18.0%)
 Ramelteon2 (4%)
 Hangekobokuto (Kampo medicine)2 (4%)
 Yokukansan (Kampo medicine)2 (4%)
 Yokukansankachimpihange (Kampo medicine)1 (2%)
 Sertraline Hydrochloride1 (2%)
 Sodium Valproate1 (2%)
  1. SD Standard deviation y = years
  2. a Each of these drugs may also be used in combination